-
B414223-5mgInformationBelvarafenib (GDC5573, HM95573, RG6185) is a selective and orally bioavailablepan-RAF kinaseinhibitor with IC50 values of 41 nM, 7 nM and 2 nM for BRAF WT, BRAF(V600E) and CRAF kinases, respectively.TargetsCRAF (Cell-free assay): BRAF
-
B607985-25mgbenazeprilat.
-
B607985-5mgbenazeprilat.
-
-
-
-
-
B338598-100mgBentamapimod is a selective JNK (Jun kinase) inhibitor that has been found to be active via oral administration. The small molecule blocks T-cell proliferation and induces apoptosis.
-
B338598-10mgBentamapimod is a selective JNK (Jun kinase) inhibitor that has been found to be active via oral administration. The small molecule blocks T-cell proliferation and induces apoptosis.
-
B338598-50mgBentamapimod is a selective JNK (Jun kinase) inhibitor that has been found to be active via oral administration. The small molecule blocks T-cell proliferation and induces apoptosis.
-
B338598-5mgBentamapimod is a selective JNK (Jun kinase) inhibitor that has been found to be active via oral administration. The small molecule blocks T-cell proliferation and induces apoptosis.
-
B275880-10mgStore at Room Temperature. The product can be stored for up to 12 months.